Pharma IQ Members

Clinical Supply
Contributor: Pharma IQ
Posted: 17/01/2017
Pharma IQ
The melanoma pipeline, which is typically underserved due to stubborn R&D challenges, is being praised for its levels of innovation as of late with 579 programs active across all stages of development, with 226 first-in-class programs in the pipeline, acting on 138 distinct first-in-class molecular targets. This accounts for 38% of all programs with a disclosed molecular target and reflects the high degree of innovation in this indication, according to business intelligence provider GBI Research. Full Article »
Posted: 04/06/2014
Bial's Ricardo Lima on Comparators in Clinical Trial Supply
In this video interview Ricardo Lima, Head of Pharmaceutical Development, Bial Research & Development, shares his insights on major challenges when it comes to comparators in clinical trial supply and what he thinks will be the major trends in clinical trial supply in the coming 18 months.  Full Video »
Contributor: Chanice Henry
Posted: 22/12/2015
Chanice Henry
Pharma IQ presents the top content pieces for 2015 in this annual bumper, so you can browse through some of this year’s best articles to feature on the portal. Full Whitepaper »